Artificial intelligence (AI) can now simulate human reasoning, learn from new information and make predictions. The value of AI was recently demonstrated in the COVID-19 pandemic, whereby AI-based approaches were used to accelerate mRNA vaccine antigen design and the conduct clinical trials, helping developers to go from a viral sequence to approved product in less than one year. But we are still in early days. In addition to machine and deep-learning, generative AI will transform vaccine development faster than we ever imagined.

In this webinar we will explore: What is AI?

The history and applications of AI
How to collect and format data for global use
AI approaches in Vaccine Discovery
Antigen and epitope discovery
Rational vaccine design
AI approaches in Vaccine Development
Product optimization / manufacturing
Clinical design and execution
Regulatory considerations

Expert panel discussions will focus on lessons learned, challenges, risks and opportunities using AI to accelerate vaccine development against global threats. The Global Vaccine and Immunization Research Forum, the central forum for research related to Immunization Agenda 2030, brings together the entire vaccine and immunization research community every two years in a meeting organized by the U.S. National Institute of Allergy and Infectious Diseases, the Bill & Melinda Gates Foundation, and the World Health Organization. Between biennial meetings, a series of webinars is addressing emerging issues of interest.

For more information go to https://web.cvent.com/event/8f2413fb-5718-48e9-95e9-2a65330c54a2/summary